Literature DB >> 19552662

Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme.

K D Ramaiah1, B Thiruvengadam, P Vanamail, S Subramanian, S Gunasekaran, N Nilamani, P K Das.   

Abstract

A diethylcarbamazine (DEC)-fortified salt intervention programme was implemented between 1982 and 1986 in Karaikal district, Union territory of Pondicherry, south India, to control Culex transmitted bancroftian filariasis. The intervention reduced the microfilaria (Mf) rate from 4.49% to 0.08%. To eliminate the residual microfilaraemia, the health department detected and treated Mf carriers from 1987 to 2005 and mass-administered drugs in 2004 and 2005. Surveillance from 1987 to 2005 revealed persistent microfilaraemia in 0.03-0.42% of the population. In 2006, we conducted a more detailed Mf survey and a child antigenaemia (Ag) survey in 15 urban wards and 17 rural villages. These surveys showed an overall Mf rate of 0.46% in the high-risk urban areas and 0.18% in the rural areas; none of the sampled children was positive for Ag. All detected Mf carriers were >20 years old. The age of the youngest Mf carrier was 30 years in urban and 21 years in rural areas, which suggests that transmission was interrupted and there was no incidence of new Mf case after cessation of DEC salt programme. Eleven of 15 urban and 15 of 17 villages were totally free from microfilaraemia. Nevertheless, three of 15 surveyed urban localities and two of 17 villages showed >1% Mf rate. Thus, it seems that (i) post-intervention very low levels of microfilaraemia can continue as long as 20 years; (ii) 0.60-0.70% Mf rate is a safe level and at this level recrudescence of infection may not occur; (iii) there can be isolated localities with >1% Mf rate and their detection for further intervention measures could be challenging in larger control/elimination programmes and (iv) the residual infection mostly gets concentrated in the adult population, in underdeveloped urban areas and in historically highly endemic or large endemic rural areas. These groups and areas should be targeted with rigorous intervention measures such as mass drug administration to eliminate the residual infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19552662     DOI: 10.1111/j.1365-3156.2009.02307.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  11 in total

1.  Epidemiological assessment of continuing transmission of lymphatic filariasis in Samoa.

Authors:  H Joseph; F Maiava; T Naseri; U Silva; P Lammie; W Melrose
Journal:  Ann Trop Med Parasitol       Date:  2011-12

Review 2.  Diurnally subperiodic filariasis in India-prospects of elimination: precept to action?

Authors:  A N Shriram; K Krishnamoorthy; B P Saha; Avijit Roy; V Kumaraswami; W A Shah; P Jambulingam; P Vijayachari
Journal:  Parasitol Res       Date:  2011-02-01       Impact factor: 2.289

3.  Midgut barrier imparts selective resistance to filarial worm infection in Culex pipiens pipiens.

Authors:  Michelle L Michalski; Sara M Erickson; Lyric C Bartholomay; Bruce M Christensen
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

4.  Epidemiological screening and xenomonitoring for human lymphatic filariasis infection in select districts in the states of Maharashtra and Karnataka, India.

Authors:  Vishal Khatri; Nitin Amdare; Nikhil Chauhan; Namdev Togre; Maryada V Reddy; Subhash L Hoti; Ramaswamy Kalyanasundaram
Journal:  Parasitol Res       Date:  2019-01-21       Impact factor: 2.289

Review 5.  A research agenda for helminth diseases of humans: intervention for control and elimination.

Authors:  Roger K Prichard; María-Gloria Basáñez; Boakye A Boatin; James S McCarthy; Héctor H García; Guo-Jing Yang; Banchob Sripa; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

Review 6.  A research agenda for helminth diseases of humans: towards control and elimination.

Authors:  Boakye A Boatin; María-Gloria Basáñez; Roger K Prichard; Kwablah Awadzi; Rashida M Barakat; Héctor H García; Andrea Gazzinelli; Warwick N Grant; James S McCarthy; Eliézer K N'Goran; Mike Y Osei-Atweneboana; Banchob Sripa; Guo-Jing Yang; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

Review 7.  A research agenda for helminth diseases of humans: the problem of helminthiases.

Authors:  Sara Lustigman; Roger K Prichard; Andrea Gazzinelli; Warwick N Grant; Boakye A Boatin; James S McCarthy; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

8.  A randomized controlled trial of increased dose and frequency of albendazole with standard dose DEC for treatment of Wuchereria bancrofti microfilaremics in Odisha, India.

Authors:  Shantanu Kumar Kar; Bhagirathi Dwibedi; Anna Salomi Kerketa; Antaryami Maharana; Sudanshu S Panda; Prafulla Chandra Mohanty; John Horton; Cherubala P Ramachandran
Journal:  PLoS Negl Trop Dis       Date:  2015-03-17

9.  Secondary mapping of lymphatic filariasis in Haiti-definition of transmission foci in low-prevalence settings.

Authors:  Naomi Drexler; Charles H Washington; Maribeth Lovegrove; Caroline Grady; Marie Denise Milord; Thomas Streit; Patrick Lammie
Journal:  PLoS Negl Trop Dis       Date:  2012-10-11

10.  Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.

Authors:  Subramanian Swaminathan; Vanamail Perumal; Srividya Adinarayanan; Krishnamoorthy Kaliannagounder; Ravi Rengachari; Jambulingam Purushothaman
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.